PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC
Visit https://www.peervoice.com/WPN860 to view the entire programme with slides. After completing “Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC”, participants will be able to: Discuss the rationale for adjuvant therapy in the management of patients with early-stage, EGFR-mutant non–small-cell lung cancer (NSCLC); Translate current evidence for EGFR TKIs in the adjuvant setting into optimal treatment plans for patients with early-stage, EGFR-mutant NSCLC; and Identify patient and disease factors that can help guide treatment decision-making in the adjuvant setting.